Apple is eradicating a blood oxygen measurement software from two of its watch fashions to keep away from a gross sales ban on the units within the U.S., Bloomberg reported. 

Late final 12 months, Apple halted gross sales of its Collection 9 and Watch Extremely 2 Apple Watch fashions over a years-long patent dispute with well being know-how firm Masimo, a maker of pulse oximeters. The software measures the saturation of oxygen within the system wearer’s pink blood cells. Low blood oxygen ranges can result in severe well being circumstances, together with harm to the mind, coronary heart and different organs, in accordance to Cleveland Clinic. 

Apple pulled the watches from retailer cabinets after the Worldwide Commerce Fee (ITC) dominated that the watches’ blood oxygen sensors violated Masimo’s patents. The units had been banned on December 26. Apple appealed the choice and the ban was paused, permitting the tech large to resume watch gross sales within the U.S.

“Optimistic step”

In a press release, Masimo referred to as Apple’s transfer to take away the software from its watches “a optimistic step towards accountability.”

“It’s particularly essential that one of many world’s largest and strongest firms respects the mental property rights of smaller firms and complies with ITC orders when it’s caught infringing,” a Masimo spokesperson mentioned.

Modified Apple watches have already been shipped to the corporate’s retail shops within the U.S., however it has not but authorised them on the market, Bloomberg reported. Apple Watch patrons who need the blood oxygen measurement software ought to verify to verify it is included. 

Apple didn’t instantly reply to CBS MoneyWatch’s request for remark. In December, the corporate mentioned it opposed the ITC’s ruling and would pursue workarounds.